This graphic details each ODN across England, along with the named ODN Clinical Lead for each.
Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management. Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.
Hepatitis C ODNs and Clinical Leads
Operational Delivery Networks (ODNs) are the new structures through which hepatitis C treatment in England is being delivered. The Network involves regional centres which manage treatment decisions and prescribing, and which have a dispersed treatment model which aims to support partnership working and access for local patients.
This graphic details each ODN across England, along with the named ODN Clinical Lead for each.England Apr 2016 Other, Strategy & Planning PDF
Guidance: Hepatitis C prevention, diagnosis and treatment in prisons in England
This document, published by The Hepatitis C Trust after convening an expert group of prison healthcare commissioners and practitioners, provides commissioners and prison healthcare teams with practical guidance regarding the implementation of opt-out BBV testing and related hepatitis C care pathways, which can be adapted and used by any prison that needs to develop, revise or update their services.UK, England Mar 2016 Reports & Research, Tools & Templates, Strategy & Planning PDF
The blood borne virus opt-out testing policy for prisons in England: An analysis of need towards full implementation
In recognition of the exceptionally high prevalence of blood borne viruses (BBVs), in particular hepatitis C, amongst people in prisons and previously very low rates of testing, in October 2013 Public Health England (PHE), NHS England and the National Offender Management Service (NOMS) agreed to introduce opt-out testing for hepatitis B, hepatitis C and HIV across the prison estate by 2016/17.UK, England Mar 2016 Reports & Research, Strategy & Planning PDF
Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland
This article uses the example of Switzerland to look at how recent developments in hepatitis C therapy might impact upon the prevention of hepatitis C vertical (i.e. mother to baby) transmission. It finds that universal screening for hepatitis C among pregnant women should be urgently re-evaluated in the light of the new treatments which are now available.Rest of World Feb 2016 Reports & Research PDF
Building the Momentum: Making the Case: World Hepatitis Summit 2015 meeting report
On 2nd - 4th September 2015 in Glasgow, the World Hepatitis Alliance staged the first ever World Hepatitis Summit in conjunction with the World Health Organisation and the Scottish Government. Over eighty countries were represented at the Summit which brought together delegates from national governments, World Hepatitis Alliance member organisations, public health and the pharmaceutical industry.Rest of World Feb 2016 Reports & Research, Strategy & Planning PDF
Scottish National Clinical Guidelines for the treatment of HCV in adults
These guidelines, published by Health Improvement Scotland and NHS National Services Scotland, provide guidance to Health Board Area Drug and Therapeutics Committees on the recommended use of available hepatitis C drugs, taking into consideration Scottish Medicines Consortium guidance, clinical effectiveness and price.UK, Scotland Feb 2016 Other, Strategy & Planning PDF
Northern Ireland Regional Hepatitis B & C Managed Clinical Network Annual Report 2015
This report, published by the Northern Ireland Hepatitis B & C Managed Clinical Network, provides an overview of the progress made by the Network in tackling hepatitis C in Northern Ireland, as well as providing a wider overview of the virus' impact in the country. As well as highlighting broader work, it also provides details of a pilot which involved a hepatitis B and C screening event aimed at the Chinese community in Belfast.UK, Northern Ireland Feb 2016 Reports & Research PDF
HCV Action good practice case study: Outreach fibroscanning and testing by Imperial College Healthcare NHS Trust
Many people with hepatitis C who access drug and alcohol services face barriers to accessing secondary care. In order to enable this group to have access to specialist services in an environment in which they felt comfortable, the Imperial College Healthcare NHS Trust developed a bespoke outreach fibroscan and testing service for the assessment of hepatitis C and liver disease. The service has operated in drug and alcohol services and homeless hostels, targeting people who may find it otherwise difficult to access secondary care.UK, Greater London Dec 2015 Case study PDF
HCV Action & PHE hepatitis C roadshow in Brighton: Presentations
On 24th November 2015, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Brighton. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C, with a particular focus on how hepatitis C can be tackled alongside HIV and other BBVs.UK, England, South East Dec 2015 Other PDF
Summary report: Hepatitis C Good Practice Roadshow, Brighton
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England on 24th November 2015. The roadshow was aimed at sharing good practice around hepatitis C and other BBVs, and instigating local action to address the virus. The report includes summaries of the talks and workshops held on the day, as well as suggested next steps to be taken in order to tackle hepatitis C more effectively in the Brighton and wider Sussex area.UK, South East Nov 2015 Reports & Research PDF